Concepedia

Tara Elisabeth Seery

TE

Statistics

Publications

13

Citations

1.4K

H-Index

11

Active since

1999

Affiliations

University of California, Irvine(Current)

Fred Hutch Cancer Center

The Barbara Ann Karmanos Cancer Institute

University of Washington

Cedars-Sinai Medical Center

Tara Elisabeth Seery is an author at University of California, Irvine specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

1999–2019

13

Publications

13

HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma

Sunil R. Hingorani, Lei Zheng, Andrea J. Bullock et al. · Journal of Clinical Oncology · 2017 · 487 citations

, , +17

Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313

Ramesh K. Ramanathan, Shannon McDonough, Philip A. Philip et al. · Journal of Clinical Oncology · 2019 · 323 citations · Full text

, , +15

Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy

Vincent Chung, Shannon McDonough, Philip A. Philip et al. · JAMA Oncology · 2016 · 177 citations · Full text

, , +17

A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105

Alexander Drilon, Siqing Fu, Manish R. Patel et al. · Cancer Discovery · 2018 · 113 citations · Full text

, , +16

Identification and characterization of <i>RET</i> fusions in advanced colorectal cancer

Anne-France Le Rolle, Samuel J. Klempner, Christopher R. Garrett et al. · Oncotarget · 2015 · 112 citations · Full text

, , +17

1–5 of 13